News
VSBC
0.500
NaN%
--
Weekly Report: what happened at VSBC last week (0908-0912)?
Weekly Report · 09/15 11:54
Weekly Report: what happened at VSBC last week (0901-0905)?
Weekly Report · 09/08 11:56
Weekly Report: what happened at VSBC last week (0825-0829)?
Weekly Report · 09/01 11:50
Weekly Report: what happened at VSBC last week (0818-0822)?
Weekly Report · 08/25 12:04
Weekly Report: what happened at VSBC last week (0811-0815)?
Weekly Report · 08/18 11:54
Weekly Report: what happened at VSBC last week (0804-0808)?
Weekly Report · 08/11 12:03
Weekly Report: what happened at VSBC last week (0728-0801)?
Weekly Report · 08/04 12:06
VitaSpring Biomedical Executives Face Ongoing Legal Challenges
TipRanks · 07/29 10:31
Weekly Report: what happened at VSBC last week (0721-0725)?
Weekly Report · 07/28 12:07
Weekly Report: what happened at VSBC last week (0714-0718)?
Weekly Report · 07/21 11:54
Weekly Report: what happened at VSBC last week (0707-0711)?
Weekly Report · 07/14 12:06
Weekly Report: what happened at VSBC last week (0630-0704)?
Weekly Report · 07/07 11:55
Weekly Report: what happened at VSBC last week (0623-0627)?
Weekly Report · 06/30 12:04
Weekly Report: what happened at VSBC last week (0616-0620)?
Weekly Report · 06/23 11:53
Weekly Report: what happened at VSBC last week (0609-0613)?
Weekly Report · 06/16 12:03
Weekly Report: what happened at VSBC last week (0602-0606)?
Weekly Report · 06/09 12:05
Weekly Report: what happened at VSBC last week (0526-0530)?
Weekly Report · 06/02 12:16
Weekly Report: what happened at VSBC last week (0519-0523)?
Weekly Report · 05/26 12:15
Weekly Report: what happened at VSBC last week (0512-0516)?
Weekly Report · 05/19 12:03
Weekly Report: what happened at VSBC last week (0505-0509)?
Weekly Report · 05/12 12:03
More
Webull provides a variety of real-time VSBC stock news. You can receive the latest news about Vitaspring Biome through multiple platforms. This information may help you make smarter investment decisions.
About VSBC
VitaSpring Biomedical Co. Ltd. is focused on building a cell medical industry. The Company invests in research and development of stem cell applications in regenerative medicine, establishes advanced medical research centers and cell production centers, and provides GTP standard stem cell preparations for the development of cellular drugs. The GTP Cell Center is the basis for its business, which is cross-domain in biotechnology medical treatment, medicine and medical materials, and focuses on the development of cell medical treatment. Its GTP standard stem cell production center is in Taipei, Taiwan for mass production of its mesenchymal stem cell (MSC), exesome, and cytopharmaceuticals. It also cooperates with affiliated companies to support the mass production and commercialization of X.MSC-related medical projects.